Optimization of cholesterol removal by probiotics in the presence of prebiotics by using a response surface method

Applied and Environmental Microbiology

Volumn 71, Issue 4, 2005, Pages 1745-1753

  Liong, M T ^a   Shah, N P ^a  

^a VICTORIA UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADDITIVES; BACTERIA; FATTY ACIDS; GROWTH KINETICS; PERTURBATION TECHNIQUES; SACCHARIFICATION; SURFACE PHENOMENA;

PERTURBATION PLOT; PREBIOTICS; QUADRATIC EFFECTS; SHORT-CHAIN FATTY ACIDS (SCFA);

CHOLESTEROL;

AMYLOSE; CHOLESTEROL; FRUCTOSE OLIGOSACCHARIDE; INULIN; MALTODEXTRIN; MANNITOL; PREBIOTIC AGENT; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID; SORBITOL;

BACTERIUM;

ARTICLE; BIOLOGICAL MODEL; CHOLESTEROL TRANSPORT; LACTOBACILLUS CASEI; MAIZE; NONHUMAN; RESPONSE SURFACE METHOD; VALIDATION PROCESS;

CARBOHYDRATE METABOLISM; CHOLESTEROL; FATTY ACIDS, VOLATILE; HUMANS; LACTOBACILLUS CASEI; MODELS, BIOLOGICAL; PROBIOTICS; SUBSTRATE SPECIFICITY;

EID: 17444415023     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.71.4.1745-1753.2005     Document Type: Article

References (25)

1. Anderson, J. W., and S. E. Gilliland. 1999. Effect of fermented milk (yoghurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. J. Am. Coll. Nutr. 18:43-50.
2. Araujo, P. W., and R. G. Brereton. 1996. Experimental design II: optimization. Trends Anal. Chem. 15:63-70.
3. Bermudez, L., C. B. Inderlied, P. Kolonoski, M. Wu, P. Aralar, and S. L. Young. 2001. Telithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatment. Antimicrob. Agents Chemother. 45:2210-2214.
4. Bruno, F. A., W. E. V. Lankaputhra, and N. P. Shah. 2002. Growth, viability and activity of Bifidobacterium spp. in skim milk containing prebiotics. J. Food Sci. 67:2740-2744.
5. Collins, M. D., and G. R. Gibson 1999. Probiotics, prebiotics and synbiotics: approaches for modulating the microbial ecology of the gut. Am. J. Clin. Nutr. 69:1052S-1057S.
6. Cox, D. R., and N. Reid. 2000. The theory of the design of experiments. Chapman and Hall, London, United Kingdom.
7. Cummings, J. H., G. T. Macfarlane, and H. N. Englyst. 2001. Prebiotic digestion and fermentation. Am. J. Clin. Nutr. 73:415S-420S.
8. Dubey, U. K., and V. V. Mistry. 1996. Effect of bifidogenic factors on growth characteristics of bifidobacteria in infant formulas. J. Dairy Sci. 79:1156-1163.
9. Dubois, M., K. A. Gilles, J. K. Hamilton, P. A. Rebers, and A. Smith. 1956. Colorimetric method for determination of sugars and related substances. Anal. Chem. 28:350-356.
10. Flickinger, E. A., B. W. Wolf, K. A. Garleb, J. Chow, G. J. Leyer, P. W. Johns, and G. C. Fahey. 2000. Glucose-based oligosaccharides exhibit different in vitro fermentation patterns and affect in vivo apparent nutrient digestibility and microbial populations in dogs. J. Nutr. 130:1267-1273.
11. Fuller, R. 1992. Probiotics: the scientific basis. Chapman and Hall, London, United Kingdom.
12. Gibson, G. R., and M. B. Roberfroid. 1995. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 125:1401-1412.
13. Kaplan, H., and W. Hutkins. 2003. Metabolism of fructooligosaccharides by Lactobacillus paracasei 1195. Appl. Environ. Microbiol. 69:2217-2222.
14. Kok, N., and A. Delzenne. 1998. Oligofructose modulates lipid metabolism alterations induced by a fat-rich diet in rats. J. Appl. Toxicol. 18:47-53.
15. Lee, S. L., and W. C. Chen. 1997. Optimization of medium composition for the production of glucosyltransferase by Aspergillus niger with response surface methodology. Enzyme Microb. Tech. 21:436-440.
16. Liong, M. T., and N. P. Shah. 2005. Acid and bile tolerance and cholesterol removal ability of lactobacilli strains. J. Dairy Sci. 88:55-66.
17. Manson, J. E., H. Tosteson, P. M. Ridker, S. Satterfield, P. Herbert, and G. T. O'Conner. 1992. The primary prevention of myocardial infarction. N. Engl. J. Med. 326:1406-1416.
18. Montgomery, D. C. 1996. Design and analysis of experiments. John Wiley and Sons, New York, N.Y.
19. Niness, K. R. 1999. Nutritional and health benefits of inulin and oligofructose. J. Nutr. 129:1402S-1406S.
20. Oh, S., S. Rheem, J. Sim, S. Kim, and Y. Baek. 1995. Optimizing conditions for the growth of Lactobacillus casei YIT 9018 in tryptone-yeast extract-glucose medium by using response surface methodology. Appl. Environ. Microbiol. 61:3809-3814.
21. Robertfroid, M. B., and N. Delzenne. 1998. Dietary fructans. Annu. Rev. Nutr. 18:117-143.
22. Rudel, L. L., and M. D. Morris. 1973. Determination of cholesterol using o-phthalaldehyde. J. Lipid Res. 14:364-366.
23. Sanders, M. E. 2000. Considerations for use of probiotic bacteria to modulate human health. J. Nutr. 130:384S-390S.
24. Shin, H. S., J. H. Lee, J. J. Pestka, and Z. Ustunol. 2000. Growth and viability of commercial Bifidobacterium spp. in skim milk containing oligosaccharides and inulin. J. Food Sci. 65:884-887.
25. Suskovic, J., B. Kos, J. Goreta, and S. Matosic. 2001. Role of lactic acid bacteria and bifidobacteria in synbiotic effect. Food Technol. Biotechnol. 39:227-235.